— Know what they know.
Not Investment Advice

ECOR

electroCore, Inc.
1W: -3.0% 1M: -6.8% 3M: +35.1% YTD: +47.0% 1Y: -10.1% 3Y: +105.8% 5Y: -80.0%
$6.69
+0.52 (+8.43%)
After Hours: $7.33 (+0.63, +9.49%)
NASDAQ · Healthcare · Medical - Devices · $54.1M · Alpha Radar Neutral · Power 44
Smart Money Score
Moderate 50
Insider
Congress
ETF Holdings
Key Statistics
Market Cap$54.1M
52W Range4.16-8.64
Volume44,833
Avg Volume68,591
Beta0.50
Dividend
Analyst Ratings
3 Buy 3 Hold 0 Sell
Consensus Buy
Company Info
CEODaniel S. Goldberger
Employees73
SectorHealthcare
IndustryMedical - Devices
IPO Date2018-06-22
200 Forge Way
Rockaway, NJ 07866
US
973 290 0097
About electroCore, Inc.

electroCore, Inc., a commercial stage medical device company, engages in the development and commercialization of a range of non-invasive vagus nerve stimulation (nVNS) therapies. The company is developing gammaCore, a prescription-only nVNS therapy for the acute treatment of pain associated with migraine and episodic cluster headache in adults. Its lead product is gammaCore Sapphire, a rechargeable and reloadable handheld device for regular or intermittent use over many years. The company was incorporated in 2005 and is headquartered in Rockaway, New Jersey.

Recent Insider Trades

NameTypeSharesPriceDate
Errico Thomas J. X-InTheMoney 22,803 $4.35 2026-03-19
Errico Thomas J. X-InTheMoney 19,252 $6.43 2026-03-19
Errico Thomas J. X-InTheMoney 22,803 $4.35 2026-03-19
Errico Thomas J. X-InTheMoney 19,252 $6.43 2026-03-19
Lev Joshua S. A-Award 2,889 2026-01-26

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms